1. Home
  2. APRE vs LUCY Comparison

APRE vs LUCY Comparison

Compare APRE & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.69

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

HOLD

Current Price

$0.88

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APRE
LUCY
Founded
2006
2017
Country
United States
United States
Employees
N/A
13
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
6.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
APRE
LUCY
Price
$0.69
$0.88
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
118.9K
62.3K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$175.92
Revenue Next Year
N/A
$205.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.87
52 Week High
$2.22
$2.90

Technical Indicators

Market Signals
Indicator
APRE
LUCY
Relative Strength Index (RSI) 33.19 35.07
Support Level $0.57 N/A
Resistance Level $0.98 $1.07
Average True Range (ATR) 0.07 0.04
MACD -0.02 -0.01
Stochastic Oscillator 2.53 13.56

Price Performance

Historical Comparison
APRE
LUCY

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.

Share on Social Networks: